Inspira Technologies has received notification of 510(k) class II clearance from the FDA for its Inspira ART100, a cardiopulmonary bypass system.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN:
- Inspira Technologies files to sell 4.42M ordinary shares for holders
- Inspira Technologies Rolls Out Revolutionary Respiratory Device
- Inspira Technologies announces start of production of Inspira ART100
- Inspira Technologies Achieves CSA Compliance Milestone
- Inspira Technologies Partners with Beilinson for Organ Transplant Tech